Loading comparison

AgeX Therapeutics vs Turn Biotechnologies

AgeX Therapeutics was a BioTime spinout pursuing cell-reprogramming and pluripotent stem-cell therapies for aging; it was reverse-merged into Serina Therapeutics in 2024 and its aging assets were sold to Juvenescence.

Longevity

Turn Biotechnologies

Develops mRNA-based epigenetic reprogramming medicines for age-related conditions via its ERA platform, with an early focus on skin.

For subscribers

Subscribe for the full comparison

Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.

Already subscribed? Sign in →